- Home
- IOVA vs HQH Comparison
IOVA vs HQH Comparison
Compare IOVA & HQH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOVA
- HQH
- Stock Information
- Founded
- IOVA 2007
- HQH 1986
- Country
- IOVA United States
- HQH United States
- Employees
- IOVA N/A
- HQH N/A
- Industry
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- HQH Finance Companies
- Sector
- IOVA Health Care
- HQH Finance
- Exchange
- IOVA Nasdaq
- HQH Nasdaq
- Market Cap
- IOVA 975.1M
- HQH 839.2M
- IPO Year
- IOVA N/A
- HQH N/A
- Fundamental
- Price
- IOVA $2.68
- HQH $15.73
- Analyst Decision
- IOVA Buy
- HQH
- Analyst Count
- IOVA 10
- HQH 0
- Target Price
- IOVA $12.22
- HQH N/A
- AVG Volume (30 Days)
- IOVA 26.0M
- HQH 183.8K
- Earning Date
- IOVA 08-07-2025
- HQH 01-01-0001
- Dividend Yield
- IOVA N/A
- HQH 11.56%
- EPS Growth
- IOVA N/A
- HQH N/A
- EPS
- IOVA N/A
- HQH 1.09
- Revenue
- IOVA $212,679,000.00
- HQH N/A
- Revenue This Year
- IOVA $86.62
- HQH N/A
- Revenue Next Year
- IOVA $69.13
- HQH N/A
- P/E Ratio
- IOVA N/A
- HQH $15.24
- Revenue Growth
- IOVA 11070.12
- HQH N/A
- 52 Week Low
- IOVA $1.64
- HQH $14.31
- 52 Week High
- IOVA $12.51
- HQH $17.94
- Technical
- Relative Strength Index (RSI)
- IOVA 53.63
- HQH 47.71
- Support Level
- IOVA $1.70
- HQH $15.58
- Resistance Level
- IOVA $4.33
- HQH $16.12
- Average True Range (ATR)
- IOVA 0.40
- HQH 0.29
- MACD
- IOVA -0.01
- HQH -0.03
- Stochastic Oscillator
- IOVA 37.26
- HQH 25.88
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
About HQH abrdn Healthcare Investors Shares of Beneficial Interest
abrdn Healthcare Investors Formerly Tekla Healthcare Investors is the United States based non-diversified closed-end management investment company. Its objective is to seek long-term capital appreciation by investing in securities of healthcare companies. In addition, the fund seeks to provide regular distribution of realized capital gains. The fund invests in the securities of public and private companies.